http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-3920813-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d78f957fb89584142d88d427f8b107b1 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/E02F9-2275 |
| classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/E02F9-22 |
| filingDate | 1973-11-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 1975-11-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_28241d59579aca18bcc337a8fe790c99 |
| publicationDate | 1975-11-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-3920813-A |
| titleOfInvention | Method of treating benign prostatic hypertrophy with aureofacin |
| abstract | Orally administered compositions for treating prostatic hypertrophy are described herein, these compositions containing an effective dose of a pharmaceutical formulation comprising aureofacin a polyenic macrolide. Also, the method of treating prostatic hypertrophy with such compositions, is described herein. |
| priorityDate | 1966-04-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 61.